Amundi’s Fate Therapeutics FATE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-4,990
| Closed | -$15.3K | – | 2157 |
|
|
2024
Q3 | $15.3K | Hold |
4,990
| – | – | ﹤0.01% | 1915 |
|
|
2024
Q2 | $15.8K | Buy |
+4,990
| New | +$15.8K | ﹤0.01% | 1857 |
|
|
2023
Q4 | – | Sell |
-7,154
| Closed | -$12.2K | – | 2012 |
|
|
2023
Q3 | $12.2K | Hold |
7,154
| – | – | ﹤0.01% | 1961 |
|
|
2023
Q2 | $34.5K | Hold |
7,154
| – | – | ﹤0.01% | 1924 |
|
|
2023
Q1 | $39.3K | Sell |
7,154
-4,664
| -39% | -$25.7K | ﹤0.01% | 1906 |
|
|
2022
Q4 | $67.6K | Sell |
11,818
-70,030
| -86% | -$401K | ﹤0.01% | 1653 |
|
|
2022
Q3 | $1.93M | Sell |
81,848
-153,845
| -65% | -$3.63M | ﹤0.01% | 1157 |
|
|
2022
Q2 | $7.43M | Sell |
235,693
-121,846
| -34% | -$3.84M | 0.01% | 839 |
|
|
2022
Q1 | $14.1M | Sell |
357,539
-23,595
| -6% | -$934K | 0.01% | 738 |
|
|
2021
Q4 | $16.1M | Sell |
381,134
-18,520
| -5% | -$782K | 0.01% | 732 |
|
|
2021
Q3 | $23.7M | Sell |
399,654
-8,833
| -2% | -$524K | 0.02% | 647 |
|
|
2021
Q2 | $35.5M | Buy |
+408,487
| New | +$35.5M | 0.02% | 525 |
|